C07K 16/1267
Gram-positive bacteria
C07K16/1267 (Gram-positive bacteria) appears on 1,258 US grants and 1,680 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,258
- Published applications
- 1,680
- Assignees
- 763
- Inventors
- 2,805
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 14 | 0 |
| 1997 | 16 | 0 |
| 1998 | 24 | 0 |
| 1999 | 21 | 0 |
| 2000 | 21 | 0 |
| 2001 | 24 | 4 |
| 2002 | 25 | 33 |
| 2003 | 25 | 48 |
| 2004 | 18 | 59 |
| 2005 | 19 | 43 |
| 2006 | 26 | 49 |
| 2007 | 21 | 46 |
| 2008 | 22 | 55 |
| 2009 | 30 | 51 |
| 2010 | 31 | 74 |
| 2011 | 37 | 82 |
| 2012 | 43 | 77 |
| 2013 | 71 | 86 |
| 2014 | 72 | 94 |
| 2015 | 52 | 108 |
| 2016 | 85 | 110 |
| 2017 | 78 | 85 |
| 2018 | 74 | 81 |
| 2019 | 61 | 79 |
| 2020 | 68 | 85 |
| 2021 | 59 | 72 |
| 2022 | 40 | 51 |
| 2023 | 40 | 60 |
| 2024 | 37 | 70 |
| 2025 | 33 | 42 |
| 2026 | 24 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Antibody specifically binding to strep-tag II tag and use thereof1 Sep 2026US 12,723,070 B2Beijing Yimiaoyiliao Co., Ltd
- Clostridium difficile antigens25 Aug 2026US 12,714,742 B2MicroPharm Limited
- Rifamycin analogs and antibody-drug conjugates thereof25 Aug 2026US 12,715,881 B2Regeneron Pharmaceuticals, Inc.
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Red Light-Controlled Protein Dimerization Systems24 Sep 2026US 2026/0285953 A1University of Washington
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Methods of classifying and treating inflammatory bowel disease17 Sep 2026US 2026/0275426 A1Baylor College of Medicine
Most cited
By later US patents
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Human antibodies derived from immunized xenomice1,057US 6,075,181 AAbgenix, Inc. · 2000
- Human antibodies derived from immunized xenomice943US 6,150,584 AAbgenix, Inc. · 2000
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000